Thrive Capital's Bet on Neuralink, OpenAI & the Future of Medicine

0:00-1:10:24

Dr. Nworah Ayogu, MD, MBA, Partner at Thrive Capital, joins Sourcery to discuss how AI is transforming drug discovery, medicine, and the economics of healthcare. A Harvard-trained physician, founding team member of Cityblock Health, former General Manager of Amazon Clinic and first Chief Medical Officer of Amazon Pharmacy, Nworah is now a partner at Thrive Capital. The investment firm has grown to over $65bn in AUM and its healthcare portfolio includes Neuralink, Nudge, Isomorphic Labs, OpenEvidence, OpenAI, Oscar Health, and Cadence. We cover AI's potential to accelerate drug development, Isomorphic Labs and Demis Hassabis, Neuralink's brain-computer interfaces, OpenEvidence's rapid adoption among physicians, personalized medicine, and the emergence of 10X doctors and nurses. We also explore some of Thrive’s breakout healthcare incubations, the next generation of trillion-dollar healthcare companies, and why AI's most important breakthroughs may happen in medicine rather than software. Disclaimer: This podcast is for informational purposes only. The views expressed are the speaker's own as of the recording date and are subject to change. Thrive funds and their affiliates have investments in certain companies discussed in this episode. References to those companies are illustrative, do not represent all investments made by Thrive, and should not be viewed as recommendations or indications of future investment performance. Past performance is not indicative of future results.

Publisher

Sourcery

Link

podcasters.spotify.com/pod/show/sourcery/episodes/Thrive-Capitals-Bet-on-Neuralink--OpenAI--the-Future-of-Medicine-e3qg1m5

Published

October 14, 2026

Duration

1h 10m

Format

Podcast

Category

Issues · Tech News

Source

RSS feed

Host

Sourcery with Molly O'Shea

S

Sourcery

@sourcery

#thrivecapitalsbet #neuralink #medicine

The Nile